Skip Navigation LinksHome > December 2013 - Volume 8 - Issue 12 > Lung Adenocarcinoma Patient Refractory to Gefitinib and Resp...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0b013e3182a00e37
Case Report

Lung Adenocarcinoma Patient Refractory to Gefitinib and Responsive to Crizotinib, with Concurrent Rare Mutation of the Epidermal Growth Factor Receptor (L861Q) and Increased ALK/MET/ROS1 Gene Copy Number

Pilotto, Sara MD*; Bria, Emilio MD*; Peretti, Umberto MD*; Massari, Francesco MD*; Garassino, Marina MD; Pelosi, Giuseppe MD, PhD; Tortora, Giampaolo MD, PhD*

Login

Article Tools

Share

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.